Morgan Lewis

Related Publications

11/16/13 Intellectual Property, Structuring Deals and Term Sheets, presented at Innovation China 2013 Conference, UCLA Anderson School of Management, Shanghai, China
09/07/13 Discovery Processes in U.S. Patent Litigation, Cross-Strait Forum on IPR Management and Dispute Resolution, Xiamen, China
View all publications

Related News

06/06/12 Morgan Lewis Advises KazMunaiGas on $1.1 Billion Financing
Morgan Lewis advised KazMunaiGas on its $1.13 billion Chinese loan.
05/01/06 Morgan, Lewis & Bockius' Beijing Office: Focused On China's New Technology Sector, The Metropolitan Corporate Counsel
Corporate Counsel interviews partner Lucas Chang on the firm's expansion into China and the unique circumstances of opening a U.S. law firm in this country.
View all news

Emerging Business Tools

visit the Entrepreneur Resource Headquarters
Photo of  Lucas S. Chang, Ph.D.

honors + affiliations

Member, California State Bar Association

Listed, Top 10 in Northern California Emerging Business and Venture Capital, The Legal 500 (2009)

Morgan, Lewis & Bockius LLP Chairman's Award (2010)

Listed, International Who's Who of Life Science Lawyers 2013 (Transactional Section)



bar admissions

  • California
print profile

Lucas S. Chang, Ph.D.
Partner 合伙人

Beijing Kerry Centre South Tower, Suite 823, 8th Fl.
No. 1 Guang Hua Road, Chaoyang District
Beijing 100020, China
Phone: +86.10.5876.3688
Fax: +86.10.5876.3501
Silicon Valley
2 Palo Alto Square
3000 El Camino Real, Suite 700
Palo Alto, CA 94306-2121 USA
Phone: +1.650.843.7258
Fax: +1.650.843.4001

Lucas S. Chang is a partner in Morgan Lewis's Business and Finance Practice and the Managing Partner and chief representative of the firm's Beijing office. As the senior partner of Morgan Lewis's firmwide Greater China Practice, he spends the majority of his time in China, Taiwan and Hong Kong, using the Beijing office as his home base, but also travels on demand to other offices and client sites worldwide.

Dr. Chang was listed among the Top 10 in Northern California Emerging Business and Venture Capital, The Legal 500 (2009), was awarded Morgan, Lewis & Bockius LLP Chairman's Award in 2010, and was listed in the International Who's Who of Life Science Lawyers 2013 (Transactional Section).

Dr. Chang focuses his practice on corporate and securities transactions including foreign direct investment, mergers and acquisitions, venture capital financing, private equity investments, and public offerings, and has handled a variety of cross-border transactions involving complex international corporate structures and special contractual arrangements designed to comply with unique legal requirements in various jurisdictions. A licensed U.S. patent attorney, Dr. Chang has prosecuted many patent applications, provided counseling on IP creation, protection and litigation to international clients, and served as the business/IP interface in several major IP litigation matters. He is also experienced in competition-related legal issues, and has participated in a number of U.S. and EU antitrust investigation and litigation matters. Dr. Chang's clients have included multinational corporations and emerging companies located in the U.S., China, Hong Kong and Taiwan in a variety of sectors such as semiconductor, electronics, computer hardware and software, internet and e-commerce, media and English education, chemicals, energy, and biotechnology and health care.

Prior to his legal career, Dr. Chang spent ten years as a research scientist and technical team leader at IBM Research and Union Carbide Corporation.

Dr. Chang is admitted to practice in California only and before the U.S. Patent and Trademark Office.





Selected Representations

Mergers and Acquisitions; Foreign Direct Investments

  • Led and participated in various M&A transactions involving public and private companies operating in the U.S., Taiwan, and China.
  • Represented various U.S. and international companies making direct investments in China and Taiwan.
  • Represented U.S. companies relocating to Taiwan in corporate inversion transactions.
  • Represented leading U.S. and international companies in asset or equity acquisitions in China and Taiwan and in joint venture formation and termination in China.

Venture Capital, Private Equity, and Public Offerings

  • Led and participated in venture capital financing transactions involving companies operating and/or registered in the United States, China, Taiwan, Hong Kong, Korea, Cayman Islands, Bermuda and British Virgin Islands, and leading international venture capital investors.
  • Participated in private equity investments in China involving both international and domestic corporate structures and leading international private equity investors.
  • Participated in and leading initial public offerings, secondary offerings and follow-on offerings on NASDAQ, NYSE, and Stock Exchange of Hong Kong involving various issuers and leading investment bankers.

Intellectual Property and Litigation

  • Represented clients and participating in intellectual property/patent infringement lawsuits in U.S. federal courts in Northern California, Eastern Texas, Massachusetts, and Southern California and in ITC 337 actions, involving companies from China and Taiwan.
  • Participated in several patent infringement and invalidation actions in Taiwan and China involving U.S. and international companies.
  • Prepared various technology transaction documents such as license agreements, joint developments agreements, foundry agreements, and supply agreements.
  • Prosecuted U.S. patent applications in semiconductor processing and design, computer architectures, data/image compression, laser optics, and chemical compositions.

Antitrust Investigation and Litigation

  • Represented public companies in Taiwan and their U.S. affiliates in U.S. and EU investigations, antitrust litigation, and class actions.

Selected Representations



  • 指导并参与多项并购交易,涉及在美国、台湾及中国大陆运营的多家上市及私营公司。
  • 代理各类美国及国际公司在中国大陆和台湾进行直接投资的事宜。
  • 代理美国公司办理公司迁回台湾的法律事宜。
  • 代理领先的美国及国际公司在中国大陆及台湾的资产或股权收购事宜以及在中国设立合资企业及终止方面的事宜。


  • 指导并参与多项风险投资融资交易,涉及在美国、中国大陆、台湾、香港、韩国、开曼群岛、百慕大群岛以及英属维京群岛运营和/或注册的公司以及领先的国际风险投资人
  • 参与多项在中国的私募基金投资交易,涉及国际及国内公司架构以及领先的国际私募基金投资人等。
  • 参与并指导各类在纳斯达克、纽约证券交易所及香港证券交易所的首次公开发行、二级发行和后续发行,涉及各类发行人及领先的投资银行。


  • 代理客户参与在北加州、东德克萨斯州、马萨诸塞州、南加州联邦法院审理的知识产权/专利侵权诉讼,以及美国国际贸易委员会337调查,涉及中国大陆及台湾的多家公司。
  • 参与涉及美国及国际公司在台湾及中国大陆的多起专利侵权和无效诉讼。
  • 起草各类技术交易文件,例如许可协议、共同开发协议、代工协议及供应协议等。
  • 代理多项美国专利申请,涉及半导体加工和设计、计算机系统结构、数据/图像压缩、激光光学以及化学成分等。


  • 代理台湾上市公司及其在美国的子公司进行美国及欧盟反垄断调查、反垄断诉讼以及集体诉讼。


  • Santa Clara University School of Law, 1994, J.D.
  • University of Washington, 1983, Ph.D. (Chemical Engineering)
  • National Taiwan University, 1977, B.S.E. (Chemical Engineering)